Synthesis and pharmacological properties of a phthalide derivative containing methoxy groups. 1976

B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski

4,6-Dimethoxy-5-hydroxyphthalide 2 was obtained on three routes: by selective demethylation of 4,5,6-trimethoxyphthalide and by the action of formaldehyde on either syringic acid or acetylsyringic acid. Pharmacological tests carried out on rats showed that the product significantly increased bile excretion, its activity being five times higher than those of dehydrocholic acid.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D008738 Methyl Ethers A group of compounds that contain the general formula R-OCH3. Ethers, Methyl
D010795 Phthalic Acids A group of compounds that has the general structure of a dicarboxylic acid-substituted benzene ring. The ortho-isomer is used in dye manufacture. (Dorland, 28th ed) Acids, Phthalic
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
November 1961, Experientia,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
January 1989, Cancer chemotherapy and pharmacology,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
August 1969, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
March 2009, Journal of materials science. Materials in medicine,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
January 1978, Arzneimittel-Forschung,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
December 1984, Talanta,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
August 1967, Archives internationales de pharmacodynamie et de therapie,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
January 2011, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
B Borkowski, and Z Kolodyńska, and A Naciazek-Wieniawska, and W Wieniawski
January 2017, Natural product research,
Copied contents to your clipboard!